No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
JP Stock MarketDetailed Quotes
4502 Takeda Pharmaceutical
- 4105.0
- +10.0+0.24%
20min DelayMarket Closed Dec 20 15:30 JST
6.53TMarket Cap45.03P/E (Static)
4121.0High4090.0Low4.82MVolume4090.0Open4095.0Pre Close19.79BTurnover4494.052wk High0.32%Turnover Ratio1.59BShares3852.052wk Low181.98EPS TTM6.23TFloat Cap8080.0Historical High45.03P/E (Static)1.52BShs Float2894.5Historical Low91.16EPS LYR0.76%Amplitude192.00Dividend TTM0.94P/B100Lot Size4.68%Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating
Express News | Hikma - Acquires Rights to a Portfolio of Takeda Brands for the Mena Region
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Takeda Pharmaceutical: Revised Extraordinary Report
Express News | Takeda Pharmaceutical's CD38 monoclonal antibody has been approved for clinical use again in China.
Takeda Pharmaceutical (TAK.US) CD38 monoclonal antibody has been approved for clinical use again in China.
Takeda Pharmaceutical's CD38 monoclonal antibody has been approved for clinical use in China again.